|
||||
 |
||||
|
Nandrolone decanoate is used in the treatment of osteoporosis in postmenopausal women at a dose of 50 mg every three weeks. It is also used for some aplastic anaemias. Dosage should be based on therapeutic response and consideration of the benefit to risk ratio. Duration of therapy will depend on the response of the condition and the appearance of adverse reactions. If possible, therapy should be intermittent. Nandrolone decanoate should be regarded as adjunctive therapy and adequate quantities of nutrients should be consumed in order to obtain maximal therapeutic effects. For example, when it is used in the treatment of refractory anemia, adequate iron intake is required for a maximal response. Anemia of renal disease: A dose of 50 to 100 mg per week is recommended for women and 100 to 200 mg per week for men. Drug therapy should be discontinued if no hematologic improvement is seen within the first six months. For children from 2 to 13 years of age, the average dose is 25 to 50 mg every 3 to 4 weeks. |
||||
|
||||
|
||||
|
||||
|
- CHECKOUT
- English
- German
- US Dollar
- Euro
- UK Pound
- Canadian Dollar
- Swiss Frank
- Australian Dollar
